Grabus Sheri D, Martin Billy R, Batman Angela M, Tyndale Rachel F, Sellers Edward, Damaj M Imad
Department of Pharmacology and Toxicology, Virginia Commonwealth University Medical Campus, PO Box 980613, Richmond, VA 23298-0613, USA.
Psychopharmacology (Berl). 2005 Mar;178(2-3):183-92. doi: 10.1007/s00213-004-2007-3. Epub 2004 Sep 10.
Although nicotine dependence and tolerance develop in rats, few studies have examined these processes in the mouse. Establishing such mouse models would eventually allow for an examination of the role of specific nicotinic receptor subtypes in mediating these processes (i.e. through the use of receptor knockouts).
The goals of the present study were to establish mouse models of nicotine dependence and tolerance.
Mice were chronically exposed to nicotine (0-200 mug/ml) in their drinking solution and assayed for plasma nicotine and cotinine levels, withdrawal signs following nicotine cessation (spontaneous withdrawal) or nicotinic antagonist administration (precipitated withdrawal), or nicotine tolerance. Dependence assays included somatic sign observations (paw tremors, backing and head shakes), tail-flick, plantar stimulation, elevated plus-maze and spontaneous activity. Tolerance was assayed using tail-flick, hot-plate and body temperature tests.
Plasma nicotine and cotinine levels were elevated during oral nicotine exposure (15.85 ng/ml and 538.00 ng/ml, respectively) and quickly declined following nicotine cessation (<1 ng/ml and <2 ng/ml, respectively), providing evidence that the oral route was pharmacologically relevant. Nicotine withdrawal increased numbers of somatic signs (spontaneous and mecamylamine-precipitated withdrawal) and/or hyperalgesia (spontaneous withdrawal only). Chronic nicotine exposure also produced tolerance, as indicated by reduced responsivity to acute nicotine in assays of analgesia and hypothermia.
These results indicate that chronic oral nicotine produces dependence and tolerance in the mouse. Further, nicotine dependence may be mediated by multiple nicotinic receptor subtypes, since specific nicotinic receptor antagonists failed to precipitate withdrawal.
尽管大鼠会产生尼古丁依赖和耐受性,但很少有研究在小鼠中考察这些过程。建立此类小鼠模型最终将有助于研究特定烟碱型受体亚型在介导这些过程中的作用(即通过使用受体基因敲除技术)。
本研究的目的是建立尼古丁依赖和耐受性的小鼠模型。
让小鼠长期饮用含尼古丁(0 - 200微克/毫升)的溶液,检测血浆尼古丁和可替宁水平、尼古丁戒断后(自然戒断)或给予烟碱拮抗剂后(诱发戒断)的戒断症状,以及尼古丁耐受性。依赖性检测包括观察躯体症状(爪颤、退缩和摇头)、甩尾、足底刺激、高架十字迷宫和自发活动。耐受性检测采用甩尾、热板和体温测试。
口服尼古丁期间血浆尼古丁和可替宁水平升高(分别为15.85纳克/毫升和538.00纳克/毫升),尼古丁戒断后迅速下降(分别<1纳克/毫升和<2纳克/毫升),这证明口服途径具有药理学相关性。尼古丁戒断增加了躯体症状的数量(自然戒断和美加明诱发戒断)和/或痛觉过敏(仅自然戒断)。慢性尼古丁暴露也产生了耐受性,在镇痛和体温过低检测中对急性尼古丁的反应性降低表明了这一点。
这些结果表明慢性口服尼古丁会使小鼠产生依赖和耐受性。此外,尼古丁依赖可能由多种烟碱型受体亚型介导,因为特定的烟碱型受体拮抗剂未能诱发戒断。